WOLFF-PARKINSON-WHITE SENDROMUNDA KARDİYOPULMONER RESÜSİTASYON SONRASI TERAPÖTİK HİPOTERMİ UYGULAMASI
[ X ]
Date
2017
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Kırıkkale Üniversitesi
Access Rights
info:eu-repo/semantics/openAccess
Abstract
Wolff-Parkinson-Whitesendromu 1930 yılında Wolff, Parkinson ve White tarafından tanımlanmıştır.Klinik olarak Wolff-Parkinson-White sendromu anormal taşiaritmi epizodları ileseyreder. Bu taşiaritmiler çocukluk çağından orta yaşlara kadar herhangi birçağda oluşabilir. Hastalığın klinik seyri, hafif veya şiddetli göğüsağrısından, senkoplu veya senkopsuz çarpıntıya veya kardiak arreste kadardeğişkenlik gösterebilir. EKG bulguları; kısa PR mesafesi ( and lt;0.12 sn.), geniş QRS kompleksi ( and gt;0.12sn.) ve ventriküllerin erkenuyarıldığını gösteren delta dalgasıdır. Wolff-Parkinson-Whitesendromu nedeniyle ventriküler fibrilasyonagiren 27 yaşındaki erkek hastaya kardiyopulmoner resüsitasyon yapıldı, kardiyakritmi geri dönen ve koma hali devam eden hasta yoğun bakıma alınarak terapötikhipotermi uygulandı. Tedavi süresince hipotermiye bağlı herhangi birkomplikasyon gelişmedi. Hasta tedavi sonrası sekelsiz olarak taburcuedildi. Hipoterminin iskemi üzerine olan etkisi,temel olarak metabolizma hızı üzerindeki etkisiyle ilişkilidir. Vücutsıcaklığındaki her 1°C’lik azalma, oksijen kullanımında %7 oranında azalmayaneden olur. Metabolizmadaki bu yavaşlama organları iskemiye karşı korumaktadır. Yazımızın amacı Wolff-Parkinson-White sendromununölümcül sonuçlara neden olabileceğini ve kardiyak arrest hastalarında erkendönemde terapötik hipotermi uygulamasının faydalarını hatırlatmaktır.
Wolff- Parkinson-White syndrome was described in 1930 by Wolff,Parkinson, and White. The clinical manifestations of Wolff-Parkinson-Whitesyndrome reflect the associated tachyarrhythmia episodes. They may have their onset at any timefrom childhood to middle age, and they can vary in severity from mild chestdiscomfort or palpitations with or without syncope to cardiac arrest. ECG findings include; shortened PR interval ( and lt;0.12 sn.) widened QRS complex ( and gt;0.12 sn.) and delta wave that indicating earlyventricular excitement. Cardiopulmonaryresuscitation was carried out to a -27 year old man who experienced ventricularfibrillation due to Wolff-Parkinson-Whitesyndrome and the cardiac rhythm returned and therapeutic hypothermia wasapplied in intensive care unit because of the continuing coma. There was nocomplication due to therapeutic hypothermia during the treatment. Our patientwas discharged without any complication after the treatment. The effects of hypothermia on ischemia aremainly, the effects on the metabolism. The reduction of body temperature foreach °C, causes 7% reduction in oxygen use. This slowdown in metabolism protectbody against ischemia. The aim of thisarticle is to underline the fatal consequences of Wolff-Parkinson-Whitesyndrome and to remind benefits in return early application of therapeutichypothermia in patients with cardiac arrest.
Wolff- Parkinson-White syndrome was described in 1930 by Wolff,Parkinson, and White. The clinical manifestations of Wolff-Parkinson-Whitesyndrome reflect the associated tachyarrhythmia episodes. They may have their onset at any timefrom childhood to middle age, and they can vary in severity from mild chestdiscomfort or palpitations with or without syncope to cardiac arrest. ECG findings include; shortened PR interval ( and lt;0.12 sn.) widened QRS complex ( and gt;0.12 sn.) and delta wave that indicating earlyventricular excitement. Cardiopulmonaryresuscitation was carried out to a -27 year old man who experienced ventricularfibrillation due to Wolff-Parkinson-Whitesyndrome and the cardiac rhythm returned and therapeutic hypothermia wasapplied in intensive care unit because of the continuing coma. There was nocomplication due to therapeutic hypothermia during the treatment. Our patientwas discharged without any complication after the treatment. The effects of hypothermia on ischemia aremainly, the effects on the metabolism. The reduction of body temperature foreach °C, causes 7% reduction in oxygen use. This slowdown in metabolism protectbody against ischemia. The aim of thisarticle is to underline the fatal consequences of Wolff-Parkinson-Whitesyndrome and to remind benefits in return early application of therapeutichypothermia in patients with cardiac arrest.
Description
Keywords
Wolff-Parkinson-White sendromu, kardiyopulmoner resüsitasyon, terapötik hipotermi, Wolff-Parkinson-White syndrome, cardiopulmonary resuscitation, therapeutic hypothermia, Health Care Administration
Journal or Series
Kırıkkale Üniversitesi Tıp Fakültesi Dergisi
WoS Q Value
Scopus Q Value
Volume
1
Issue
1-41
